News

PipelineReview.com6h
Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care
PARIS, France I June 10, 2025 I As metabolic dysfunction-associated steatohepatitis (MASH) emerges as one of the most dangerous and underdiagnosed drivers of ...
PipelineReview.com6h
Myosin Therapeutics Receives FDA Clearance to Initiate First-in-Human Trial of MT-125 in Glioblastoma
JUPITER, FL, USA I June 9, 2025 I Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular ...
PipelineReview.com6h
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
MILAN, Italy I June 06, 2025 I Italfarmaco S.p.A. announced today that the European Commission (EC) has granted conditional marketing authorisation for ...
PipelineReview.com21h
Axio BioPharma and Likarda Announce Strategic Partnership to Accelerate Biologic Drug Development and Delivery
Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes.
PipelineReview.com23h
Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i
Company to host conference call and webcast today at 8:00 A.M. ET ...
PipelineReview.com23h
Taconic Biosciences Enters Into an Exclusive License Agreement With Helmholtz Munich to Expand Its CRISPR/Cas9 Gene Editing Services
RENSSELAER, NY, USA I June 09, 2025 I Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license ...
PipelineReview.com23h
Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy
BOSTON, MA, USA I June 09, 2025 I Anodyne Nanotech, a clinical-stage biotech company, today announced new preclinical data demonstrating that administration ...